Glycosylated Hemoglobin Correlates with Anti-human Transglutaminase Antibodies in Children and Youths with Type 1 Diabetes and New Onset Celiac Disease

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ISPAD - International Society for Pediatric and Adolescent Diabetes

The International Society for Pediatric and Adolescent Diabetes (ISPAD) is a professional organization whose aims are to promote clinical and basic science, research, education and advocacy in children, adolescents and young adults with diabetes. The strength of ISPAD lies in the scientific and clinical expertise in childhood and adolescent diabetes ...
read more ↘ of its members. ISPAD is the only international society focusing specifically on all types of childhood diabetes. Our mission is a better world for children, adolescents and young adults with diabetes. Learn more by visiting: https://www.ispad.org/
↖ read less

Videos
Events
Webinars
2020 2021 2022 2023 2024
ISPAD's 49th Annual Conference 2023
Opening Ceremony Exploring Advancements in the T1D Treatment How to Advocate for Psychology Services in the Diabetes Center Oral Sessions II: Diabetes Complications Care Models and Value Based Health Care Joint Symposium ISPAD ESPE Focus on the Endocrine Pancreas The Skin in Times of Diabetes Technology Oral Sessions I: Diabetes Care Education and Genetics Guideline Session: What's New? Diabetes in School Breaking News Changing Diabetes in Children Nutrition Joint Symposium ISPAD-JDRF Global Pediatric Diabetes Development: What Can ISPAD Members Do? President's Welcome and Opening Lecture Prediction and Prevention of T1DM Be the Change: Implementing Diabetes Care in Low- and Middle-Income Countries Oral Sessions IV: Psychological and Psychosocial Aspects of Diabetes Meet the Editor JENIOUS Mentorship Meeting Experiencing the Potential of the MiniMed 780G System in the Young with Type 1 Diabetes Oral Session III: Obesity, Type 2 Diabetes, Monogenic and Other Forms of Diabetes Meet the Expert: Diabetes Treatment Evening Symposium: The Now Known Disrupting the Pathogenesis of T1D Health, Outcome and Value Pushing the Boundaries of T1D Technology What's New in Type 2? Oral Sessions V: Screening, Preventing, and Epidemiology of Diabetes Keeping it Cool with Insulin PRO's in Type 1 Diabetes Care Diabetes and Exercise Oral Sessions VI: Technology, Nutrition, Exercise, and Adjunctive Therapies Automated Insulin Delivery with mylife CamAps FX to Manage Type 1 Diabetes in Childhood and Adolescence: Practical Insights #dedoc Symposium: The Patient Voice at ISPAD Establishing the Role of the MiniMed 780G System in the Pediatric Population with Type 1 Diabetes IDF Workshop on Kids Making the Diabetes Talk Connect What's Up On T1D Therapeutics Highlights: Diabetes Publications 2022 Small Children - Big Challenges in Diabetes Management Mind the Gap Guiding Young People with Diabetes into Adult Care Joint Symposium ISPAD - ATTD Diabetes Registries, Not Only for Researchers: How and Why to Start Closing Ceremony Debate: Should We Screen for and Treat Asymptomatic Coelic Disease in Type 1 Diabetes